Literature DB >> 20549277

Frequency of antinuclear antibodies in mestizo Mexican children with morphea.

Elizabeth Guevara-Gutiérrez1, Janeth Yinh-Lao, Patricia García-Gutiérrez, Alberto Tlacuilo-Parra.   

Abstract

Morphea is a disease that affects connective tissue and microvessels. Its pathogenesis is unknown, but several autoimmune factors participate. Our objective was to determine the frequency of antinuclear antibodies (ANAs) in pediatric patients with morphea and to establish their relation with the clinical variants and disease activity. A cross-sectional study was carried out from January 1999 to January 2008 in patients with morphea seen at the Instituto Dermatologico de Jalisco. ANAs were determined through an indirect immunoflourescent method, and the immunospecificity was done with a double immunodiffusion technique in agarose gel. A total of 34 children were included in the study, 74% of the female gender. Plaque morphea was the most common variant, present in 44% of the cases, followed by linear morphea in 38%, and generalized morphea in 18%. ANAs were positive in 29%, with homogenous immunoflourescense as the most frequent pattern (70%). Of the ANA-positive patients, 83% had generalized morphea, and in 70% of the cases the disease were considered as active. The frequency of ANA-positive children with morphea was 29%, and seems to be related to more extensive disease. No previous studies exist on this topic in the mestizo Mexican population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20549277     DOI: 10.1007/s10067-010-1515-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  25 in total

1.  Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing.

Authors:  Daniel H Solomon; Arthur J Kavanaugh; Peter H Schur
Journal:  Arthritis Rheum       Date:  2002-08

2.  Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma.

Authors:  R Sgonc; M S Gruschwitz; H Dietrich; H Recheis; M E Gershwin; G Wick
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Analysis of collagen gene expression by cultured fibroblasts in morphoea.

Authors:  A Hatamochi; M Ono; M Arakawa; K Takeda; H Ueki
Journal:  Br J Dermatol       Date:  1992-03       Impact factor: 9.302

4.  Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.

Authors:  F Zulian; B H Athreya; R Laxer; A M Nelson; S K Feitosa de Oliveira; M G Punaro; R Cuttica; G C Higgins; L W A Van Suijlekom-Smit; T L Moore; C Lindsley; J Garcia-Consuegra; M O Esteves Hilário; L Lepore; C A Silva; C Machado; S M Garay; Y Uziel; G Martini; I Foeldvari; A Peserico; P Woo; J Harper
Journal:  Rheumatology (Oxford)       Date:  2005-12-20       Impact factor: 7.580

5.  A practical guide for serologic evaluation of autoimmune connective tissue diseases.

Authors:  D F Mutasim; B B Adams
Journal:  J Am Acad Dermatol       Date:  2000-02       Impact factor: 11.527

Review 6.  Scleroderma in childhood: a 35-year history of cases and review of the literature.

Authors:  C R Bottoni; K A Reinker; R D Gardner; D A Person
Journal:  J Pediatr Orthop       Date:  2000 Jul-Aug       Impact factor: 2.324

Review 7.  Localized scleroderma in childhood: a report of 30 cases.

Authors:  Y Uziel; B R Krafchik; E D Silverman; P S Thorner; R M Laxer
Journal:  Semin Arthritis Rheum       Date:  1994-04       Impact factor: 5.532

8.  Antihistone antibodies in linear scleroderma variants.

Authors:  Rokea A el-Azhary; Carole C Aponte; Audrey M Nelson; Amy L Weaver; Henry A Homburger
Journal:  Int J Dermatol       Date:  2006-11       Impact factor: 2.736

9.  Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma.

Authors:  S Sato; M Fujimoto; H Ihn; K Kikuchi; K Takehara
Journal:  J Am Acad Dermatol       Date:  1994-10       Impact factor: 11.527

10.  Antinuclear antibodies in children with localized scleroderma.

Authors:  A M Rosenberg; Y Uziel; B R Krafchik; S A Hauta; P A Prokopchuk; E D Silverman; R M Laxer
Journal:  J Rheumatol       Date:  1995-12       Impact factor: 4.666

View more
  4 in total

1.  Linear morphea involving the underlying muscle.

Authors:  Naoki Yamamoto; Akihiro Dejima; Kenkou Hasatani
Journal:  Clin Rheumatol       Date:  2021-05-27       Impact factor: 2.980

2.  Frequency of antinuclear antibody positivity in patients with pattern hair loss.

Authors:  Won Joon Choi; Jung Eun Kim; Hoon Kang
Journal:  Ann Dermatol       Date:  2015-03-24       Impact factor: 1.444

Review 3.  Immunopathogenesis of Pediatric Localized Scleroderma.

Authors:  Kathryn S Torok; Suzanne C Li; Heidi M Jacobe; Sarah F Taber; Anne M Stevens; Francesco Zulian; Theresa T Lu
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

4.  A case of gestational gigantomastia in a 37-years-old woman associated with elevated ANA: a casual linkage?

Authors:  Nicola Zingaretti; Fabrizio De Biasio; Michele Riccio; Nastassia Nardini; Laura Mariuzzi; Pier Camillo Parodi
Journal:  Pan Afr Med J       Date:  2017-07-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.